Penumbra Expands Computer-Aided Thrombectomy Offerings with Lightning Bolt 7 Technology Designed to Rapidly Remove Blood Clots with Modulated Aspiration
Retrieved on:
Thursday, June 1, 2023
Columbia University, Columbia University Irving Medical Center, Maxident, Lightning, FRCS, Amputation, ALI, Quality of life, CIS, Artery, Libin Cardiovascular Institute, Friction, MD, Patient, Physician, FACS, Buerger's test, Mortality, FDA, Regulation of tobacco by the U.S. Food and Drug Administration, NYSE, Food, Pharmaceutical industry, Birth control
Lightning Bolt 7 introduces a new method for removing blood clots, modulated aspiration, which pairs Penumbra's Lightning Intelligent Aspiration technology with an advanced microprocessor algorithm.
Key Points:
- Lightning Bolt 7 introduces a new method for removing blood clots, modulated aspiration, which pairs Penumbra's Lightning Intelligent Aspiration technology with an advanced microprocessor algorithm.
- When used together, Lightning Bolt 7 is designed to enhance the ability to rapidly remove large, fibrous blood clots in the arteries with minimal blood loss, addressing conditions such as acute limb ischemia (ALI), hibernating thrombus and visceral occlusions.
- "Advancements like Lightning Bolt 7 provide a critical frontline option for physicians to treat patients and improve patient outcomes."
- Powered by the Penumbra ENGINEĀ®, Lightning Bolt 7 is engineered to detect the difference between blood clot and blood flow.